Research Article
Polymeric Nanosuspensions for Enhanced Dissolution of Water Insoluble Drugs
Table 4
Heat flow and endothermic peaks of drug formulations obtained from DSC measurements.
| Drug | Sample label | Heat flow (W/g) | Endotherm peaks (°C) |
| NIF | | −2.435 | 155.69 | A2 | −1.049 and −1.216 | 88.93 and 160.46 | A3 | −0.8706 and −1.053 | 83.45 and 152.11 | A4 | −0.804 and −0.7874 | 82.97 and 142.82 |
| CBZ | | −2.473 | 155.69 | A2 | −0.867 and −1.765 | 89.41 and 156.17 | A3 | −1.298 and −1.125 | 93.70 and 150.68 | A4 | −1.152 and −0.8744 | 97.56 and 143.05 |
| IBP | | −1.69 | 157.60 | A2 | −1.082 and −1.404 | 96.80 and 157.36 | A3 | −1.318 and −1.024 | 93.22 and 152.35 | A4 | −1.115 and −0.8825 | 98.47 and 145.20 |
|
|